Cipher Pharmaceuticals Inc Share Price Nasdaq
Equities
CA17253X1050
Pharmaceuticals
Sales 2024 * | 3.01Cr 2.19Cr 182.89Cr | Sales 2025 * | 2.94Cr 2.13Cr 178.37Cr | Capitalization | 21Cr 16Cr 1.3TCr |
---|---|---|---|---|---|
Net income 2024 * | 1.8Cr 1.31Cr 109.21Cr | Net income 2025 * | 1.6Cr 1.16Cr 97Cr | EV / Sales 2024 * | 7.12 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 7.3 x |
P/E ratio 2024 * |
12
x | P/E ratio 2025 * |
13.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.04% |
Latest transcript on Cipher Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/22/15 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 08/16/08 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 21/23/21 |
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
1st Jan change | Capi. | |
---|---|---|
+45.82% | 77TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.45% | 25TCr | |
-0.78% | 22TCr | |
+11.88% | 22TCr | |
+5.90% | 16TCr | |
-0.73% | 16TCr |